| $337M | ||
| $259M | ||
| $100M | ||
| $79M | ||
| $60M | ||
| $58M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy. It has a license agreement with New Life Therapeutics PTE, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin 6. Sonnet BioTherapeutics Holdings, Inc. is based in Princeton, New Jersey.
Over the last 12 months, insiders at Sonnet BioTherapeutics Holdings, Inc. have bought $0 and sold $0 worth of Sonnet BioTherapeutics Holdings, Inc. stock.
On average, over the past 5 years, insiders at Sonnet BioTherapeutics Holdings, Inc. have bought $103,277 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 34,375 shares for transaction amount of $55,000 was made by Mohan Pankaj (Chairman, President and CEO) on 2023‑10‑27.
| 2023-10-27 | Mohan Pankaj | Chairman, President and CEO | 34,375 2.7322% | $1.60 | $55,000 | +25.65% | ||
| 2023-10-27 | Rao Raghu | director | 15,625 1.2419% | $1.60 | $25,000 | +25.65% | ||
| 2023-06-14 | Dexter Susan | Chief Technical Officer | 10,000 0.0581% | $0.70 | $7,000 | -88.47% | ||
| 2023-05-30 | Dyrness Albert D. | director | 23,255 0.1328% | $0.47 | $10,883 | -82.67% | ||
| 2023-05-17 | Bhatt Nailesh | director | 25,000 0.1518% | $0.23 | $5,800 | -61.35% | ||
| 2023-05-15 | Mohan Pankaj | Chairman, President and CEO | 371,600 2.2431% | $0.22 | $82,867 | -59.81% | ||
| 2023-03-15 | Mohan Pankaj | Chairman, President and CEO | 60,000 0.3794% | $0.58 | $35,100 | -70.60% | ||
| 2021-06-09 | Mohan Pankaj | Chairman, President and CEO | 32,000 0.144% | $1.55 | $49,580 | -82.58% | ||
| 2021-06-09 | Kenney Richard T | Chief Medical Officer | 15,000 0.0671% | $1.54 | $23,100 | -82.58% | ||
| 2021-05-19 | Kenney Richard T | Chief Medical Officer | 10,000 0.0444% | $1.55 | $15,500 | -81.05% | ||
| 2020-06-11 | Dyrness Albert D. | director | 2,409 0.0221% | $4.01 | $9,660 | -34.28% | ||
| 2020-06-10 | Mohan Pankaj | Chairman, President and CEO | 2,400 0.0216% | $4.09 | $9,816 | -36.76% | ||
| 2020-03-23 | Pruitt Michael D | CEO, Chairman | 7,000 0.0699% | $0.58 | $4,078 | -78.31% | ||
| 2020-03-23 | Glick Frederick L | President | 5,000 0.0433% | $0.51 | $2,528 | -78.31% | ||
| 2020-01-31 | Pruitt Michael D | CEO, Chairman | 206 – | $0 | $0 | -82.08% | ||
| 2019-12-10 | Pruitt Michael D | CEO, Chairman | 200 0.0004% | $0.62 | $124 | -75.21% | ||
| 2019-11-19 | Pruitt Michael D | CEO, Chairman | 2,000 0.0039% | $0.70 | $1,410 | -78.24% | ||
| 2019-11-17 | Pruitt Michael D | CEO, Chairman | 165 0.0003% | $0.64 | $106 | -76.27% | ||
| 2019-08-23 | Pruitt Michael D | CEO, Chairman | 1,000 0.0008% | $0.57 | $572 | -39.70% | ||
| 2019-08-19 | Pruitt Michael D | CEO, Chairman | 5,000 0.0036% | $0.61 | $3,050 | -35.57% |
| SPITCAUFSKY LARRY | 89689 2.8331% | $864,601.96 | 7 | 8 | ||
| Mohan Pankaj | Chairman, President and CEO | 59526 1.8803% | $573,830.64 | 5 | 0 | <0.0001% |
| Kenney Richard T | Chief Medical Officer | 50000 1.5794% | $482,000.00 | 2 | 0 | <0.0001% |
| Pruitt Michael D | CEO, Chairman | 35462 1.1202% | $341,853.68 | 74 | 0 | |
| Dexter Susan | Chief Technical Officer | 33667 1.0635% | $324,549.88 | 1 | 0 | <0.0001% |
| Bhatt Nailesh | director | 30733 0.9708% | $296,266.12 | 1 | 0 | <0.0001% |
| Dyrness Albert D. | director | 28962 0.9148% | $279,193.68 | 2 | 0 | <0.0001% |
| Kraut Gregory Evan | director | 24662 0.779% | $237,741.68 | 7 | 0 | |
| Carroll J Michael | director | 20500 0.6475% | $197,620.00 | 1 | 0 | |
| Rao Raghu | director | 16813 0.5311% | $162,077.32 | 1 | 0 | +25.65% |
| Glick Frederick L | President | 4000 0.1263% | $38,560.00 | 3 | 0 | |
| PAGE RUSSELL JACOB | director | 1000 0.0316% | $9,640.00 | 1 | 0 | |
| SMITH DARREN HOWARD | CFO of S. African Subsidiary | 811 0.0256% | $7,818.04 | 2 | 0 | |
| Roberson Mark Daniel | Chief Operating Officer | 100 0.0032% | $964.00 | 2 | 0 | |
| PALISADES MASTER FUND LP | 10 percent owner | 0 0% | $0 | 0 | 26 |
$14,315,062 | 61 | -6.21% | $39.79M | |
$17,268,389 | 57 | -18.16% | $28.2M | |
$6,204,522 | 45 | 1.91% | $25.72M | |
$23,895,365 | 34 | -37.28% | $33.51M | |
$36,557,692 | 17 | 3.38% | $32.29M | |
$139,007,129 | 16 | 47.16% | $29.5M | |
$11,247,055 | 15 | -26.49% | $37.51M | |
$156,484,110 | 12 | 52.55% | $25.05M | |
$19,300,035 | 11 | 45.88% | $33.46M | |
Sonnet BioTherapeutics Holdings, Inc. (SONN) | $309,830 | 10 | -55.78% | $30.52M |
$31,978,951 | 10 | -70.03% | $38.3M | |
$119,676,458 | 9 | -37.15% | $39.28M | |
$189,648 | 9 | -52.20% | $24.99M | |
$5,524,590 | 7 | 7.40% | $28.22M | |
$5,269,662 | 7 | -11.38% | $32.42M | |
$1,472,879 | 6 | -13.59% | $31.08M | |
$157,740 | 3 | 153.95% | $29.19M | |
$100,266 | 2 | 3.17% | $29.19M | |
$500,000 | 1 | -22.94% | $27.35M |
| Increased Positions | 5 | +41.67% | 158,571 | +178.03% |
| Decreased Positions | 5 | -41.67% | 86,378 | -96.98% |
| New Positions | 3 | New | 158,412 | New |
| Sold Out Positions | 4 | Sold Out | 82,865 | Sold Out |
| Total Postitions | 12 | 0% | 161,263 | +81.05% |
| Virtu Financial Llc | $54.00 | 1.32% | 39,647 | +39,647 | New | 2024-12-31 |
| Citadel Advisors Llc | $33.00 | 0.8% | 24,013 | +24,013 | New | 2024-12-31 |
| Two Sigma Investments, Lp | $26.00 | 0.64% | 19,203 | +19,203 | New | 2024-12-31 |
| Tower Research Capital Llc (Trc) | $8.00 | 0.2% | 6,100 | +5,722 | +1,513.76% | 2024-12-31 |
| Blackrock, Inc. | $0 | <0.01% | 65 | 0 | 0% | 2025-03-31 |
| Carolina Wealth Advisors, Llc | $0 | <0.01% | 32 | 0 | 0% | 2025-03-31 |
| Bank Of America Corp /De/ | $0 | 0% | 5 | +5 | New | 2024-12-31 |
| Ubs Group Ag | $0 | 0% | 3 | +3 | New | 2024-12-31 |
| Citigroup Inc | $0 | 0% | 2 | +2 | New | 2024-12-31 |